• 儀器無(wú)憂網(wǎng)首頁(yè)
首頁(yè) >  儀器無(wú)憂網(wǎng)品牌優(yōu)搜庫(kù) >  K > KB

美國(guó) . Kamiya Biomedical

logo

KB

Kamiya Biomedical

美國(guó)Kamiya Biomedical Company www.kamiyabiomedical.com
Kamiya Biomedical Company 是一家獨(dú)立的擁有國(guó)際市場(chǎng)的美國(guó)公司,位于美國(guó)加利福尼亞州,1983年3月成立。Kamiya致力于為生命科學(xué)和醫(yī)藥機(jī)構(gòu)提供高質(zhì)量的具有創(chuàng)新性的實(shí)驗(yàn)室研究和診斷手段(產(chǎn)品)。 
這家公司的第一個(gè)產(chǎn)品是用于信號(hào)轉(zhuǎn)換研究的the cutting edge protein kinase inhibitors staurosporine 和K252a。在1990年,KAMIYA成為第一家向美國(guó)研究機(jī)構(gòu)引進(jìn)anti-Fas多抗體的公司。
如今KAMIYA生產(chǎn)的產(chǎn)品包括1500多種不同的臨癥前期的(即潛伏期的)試驗(yàn)產(chǎn)品、用于人類(lèi)的生物標(biāo)志物分析的產(chǎn)品、酶抑制劑、酶基片、單抗、多抗和用于研究細(xì)胞死亡、抗多藥性、氧化DNA損壞和修復(fù)、骨生物學(xué)、癌癥、心臟健康、炎癥、緊張、肥胖和糖尿病的小分子產(chǎn)品。
具體產(chǎn)品信息請(qǐng)點(diǎn)擊:

KAMIYA BIOMEDICAL COMPANY was founded by Kohji Kamiya in March of 1983 in Thousand Oaks, California, with the purpose of supplying the life science and medical communities with innovative laboratory research and diagnostic tools of the highest quality. KAMIYA is an independent American company that serves worldwide markets.
The companys first products were the cutting edge protein kinase inhibitors staurosporine and K252a for signal transduction research. In 1990, KAMIYA became the first company to introduce anti-Fas monoclonal antibodies to the U.S. research community.
Today KAMIYA's product lines include over 1500 different preclinical testing products, human biomarker assays, enzyme inhibitors, enzyme substrates, monoclonal and polyclonal antibodies, and small molecules for research in apoptosis, multidrug resistance, oxidative / DNA damage and repair, bone biology, cancer, cardiac health, inflammation, stress, obesity, and diabetes.
In 1993, KAMIYA introduced a full line of clinical diagnostic and research immunoassay products for lipid assessment, coagulation, inflammation, diabetes, nutritional assessment, and serum protein measurement based on immunoturbidimetric technology. The K-ASSAYs were developed for use on standard chemistry analyzers, requiring no mixing, dissolving, or dilution of reagent or sample, at an exceptional value.
KAMIYA now has the broadest product line of liquid serum protein immunoassay reagents of any company in the U.S., and supplies clinical diagnostic reagents to leading hospitals, medical centers, clinical laboratories, clinical reference labs, research facilities, distributors, and diagnostic instrument companies worldwide.
Look for KAMIYA BIOMEDICAL COMPANY to continue to offer the life science and medical communities with innovative and cutting edge laboratory research and diagnostic tools.